Q-Pharm conducts a wide range of clinical trial studies including:

• First-time-in-humans studies, both single ascending dose and multiple ascending dose (from short to long term confinements).
• Pharmacokinetic studies including food effect studies, drug-drug interaction studies, Japanese bridging studies and other pharmacokinetic studies supporting formulation development activities.
• Bioequivalence studies, which are conducted to a very high standard and have supported successful product registrations in Australia, New Zealand, USA, UK and many other countries in Europe, Brazil, and various countries in Asia and the Middle East.
• Vaccine studies.